Absorption, distribution, metabolism, and excretion of [14C]sesamin in rats

被引:33
|
作者
Tomimori, Namino [1 ]
Rogi, Tomohiro [1 ]
Shibata, Hiroshi [1 ]
机构
[1] Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto, Japan
关键词
Distribution; Excretion; Metabolites profile; Pharmacokinetics; Sesamin; HUMAN LIVER; CARDIOVASCULAR HYPERTROPHY; ANTIOXIDATIVE METABOLITES; NITRIC-OXIDE; SESAME SEED; IN-VIVO; ALCOHOL; LIGNANS; HUMANS; CYTOCHROME-P450;
D O I
10.1002/mnfr.201600844
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Scope: Sesamin is a major lignan in sesame seeds and has various physiological effects. Although metabolism of sesamin by cytochrome P450 or intestinal microflora has been reported, little is known concerning the mass balance, pharmacokinetics, and tissue distribution of sesamin. Methods and results: Absorption, distribution, metabolism, and excretion of [C-14] sesamin were investigated after a single oral dose of 5mg/kg in rats. Sesamin was absorbed with peak plasma radioactivity at 1.0 h and declined with a terminal half-life 4.7 h. The cumulative excretion of radioactivity was 37.5 +/- 3.1% in urine and 58.7 +/- 4.8% in feces. In bile duct-cannulated rats, the cumulative excretion of radioactivity was 66.3 +/- 8.4% in bile and 27.8 +/- 10.2% in urine. Tissue distribution was investigated using quantitative whole-body autoradiography. Radioactivity was widely distributed over the whole body and was highly detected in the liver and kidney. The metabolites profile was examined using radiochromatography. Sesamin was mainly distributed in the form of conjugate metabolites. Conclusions: Sesamin was absorbed efficiently and distributed over the whole body. In particular, sesamin was highly distributed in the form of the metabolites in the liver and kidney. The results of this study are useful in elucidating the action mechanism of sesamin.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats
    Xin-mei Li
    Yuan-dong Zheng
    Yi-fan Zhang
    Xia-juan Huan
    Chen Yang
    Meng-ling Liu
    Xiao-kun Shen
    Chun-hao Yang
    Xing-xing Diao
    Cancer Chemotherapy and Pharmacology, 2022, 90 : 499 - 510
  • [32] Study of the absorption, metabolism, and excretion of (14C)-ramelteon (TAK-375).
    Stevenson, S
    Cornelissen, K
    Clarke, E
    Hibberd, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P22 - P22
  • [33] Dermal absorption and distribution of 14C carbaryl in Wistar rats
    Tos-Luty, S
    Tokarska-Rodak, M
    Latuszynska, J
    Przebirowska, D
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2001, 8 (01) : 47 - 50
  • [34] Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration
    Matthew Hoffmann
    Claudia Kasserra
    Josephine Reyes
    Peter Schafer
    Jolanta Kosek
    Lori Capone
    Anastasia Parton
    Heasook Kim-Kang
    Sekhar Surapaneni
    Gondi Kumar
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 489 - 501
  • [35] ABSORPTION AND DISTRIBUTION OF ULTRATRACE EXOGENOUS 14C UREA IN RATS
    Wang, Li
    Shen, Hongtao
    Tang, Junsen
    Zhang, Guofeng
    Qi, Linjie
    Chen, Dingxiong
    Wu, Kaiyong
    Han, Xinyi
    Ouyang, He
    He, Yun
    Yang, Pucheng
    Zhang, Xue
    Xia, Chunbo
    RADIOCARBON, 2024, 66 (05) : 1450 - 1459
  • [36] Absorption, metabolism, excretion, and safety of [14C]almonertinib in healthy Chinese subjects
    Zhou, Chen
    Xie, Lijun
    Liu, Wei
    Zhang, Lingling
    Zhou, Sufeng
    Wang, Lu
    Chen, Juan
    Li, Huan
    Zhao, Yuqing
    Zhu, Bei
    Ding, Sijia
    Zhang, Chen
    Shao, Feng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
  • [37] Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration
    Hoffmann, Matthew
    Kasserra, Claudia
    Reyes, Josephine
    Schafer, Peter
    Kosek, Jolanta
    Capone, Lori
    Parton, Anastasia
    Kim-Kang, Heasook
    Surapaneni, Sekhar
    Kumar, Gondi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 489 - 501
  • [38] EXCRETION AND METABOLISM OF [14C]-PYRIDOSTIGMINE IN RAT
    BIRTLEY, RDN
    ROBERTS, JB
    THOMAS, BH
    WILSON, A
    BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (02): : 393 - &
  • [39] Metabolism of furametpyr.: 2.: 14C excretion, 14C concentrations in tissues, and amounts of metabolites in rats
    Nagahori, H
    Yoshino, H
    Tomigahara, Y
    Isobe, N
    Kaneko, H
    Nakatsuka, I
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (11) : 5760 - 5767
  • [40] ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF [C-14] EBASTINE AFTER A SINGLE ADMINISTRATION IN RATS
    FUJII, T
    MATSUMOTO, S
    AMEJIMA, H
    HATOYAMA, T
    NAKAO, M
    KAGEMOTO, A
    TANAKA, K
    MIYAZAKI, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-1 (04): : 527 - 538